These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22250847)

  • 1. The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.
    Ezeabogu I; Copenhaver MM; Potrepka J
    AIDS Care; 2012; 24(3):386-93. PubMed ID: 22250847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users.
    Copenhaver MM; Lee IC; Margolin A; Bruce RD; Altice FL
    Subst Abus; 2011 Jan; 32(1):16-26. PubMed ID: 21302180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An experiential program to reduce AIDS risk among female sex partners of injection-drug users.
    Rhodes F; Wolitski RJ; Thornton-Johnson S
    Health Soc Work; 1992 Nov; 17(4):261-72. PubMed ID: 1478552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users.
    Waldrop-Valverde D; Jones DL; Weiss S; Kumar M; Metsch L
    AIDS Care; 2008 Nov; 20(10):1202-10. PubMed ID: 19012081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
    Kalichman SC
    Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.
    Shrestha R; Karki P; Huedo-Medina TB; Copenhaver M
    J Assoc Nurses AIDS Care; 2017; 28(1):85-94. PubMed ID: 27769735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive impairment and HIV risk factors: a reciprocal relationship.
    Anand P; Springer SA; Copenhaver MM; Altice FL
    AIDS Behav; 2010 Dec; 14(6):1213-26. PubMed ID: 20232242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
    Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
    AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial and behavioral factors associated with risk of sexually transmitted diseases, including human immunodeficiency virus infection, among urban high school students.
    Shafer MA; Boyer CB
    J Pediatr; 1991 Nov; 119(5):826-33. PubMed ID: 1941394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
    Safren SA; O'Cleirigh CM; Bullis JR; Otto MW; Stein MD; Pollack MH
    J Consult Clin Psychol; 2012 Jun; 80(3):404-15. PubMed ID: 22545737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.
    Meade CS; Conn NA; Skalski LM; Safren SA
    J Behav Med; 2011 Apr; 34(2):128-38. PubMed ID: 20857187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men.
    McPherson-Baker S; Malow RM; Penedo F; Jones DL; Schneiderman N; Klimas NG
    AIDS Care; 2000 Aug; 12(4):399-404. PubMed ID: 11091772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population.
    Fisher JD; Fisher WA; Misovich SJ; Kimble DL; Malloy TE
    Health Psychol; 1996 Mar; 15(2):114-23. PubMed ID: 8681919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD; Williams AB; Truong HT; Do NH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
    Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
    Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART.
    Madhombiro M; Dube-Marimbe B; Dube M; Chibanda D; Zunza M; Rusakaniko S; Stewart D; Seedat S
    BMC Psychiatry; 2017 Jan; 17(1):44. PubMed ID: 28129756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.
    Shrestha R; Altice FL; Karki P; Copenhaver MM
    AIDS Behav; 2018 Aug; 22(8):2640-2649. PubMed ID: 29582199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol.
    Claborn K; Becker S; Operario D; Safren S; Rich JD; Ramsey S
    Addict Sci Clin Pract; 2018 Apr; 13(1):12. PubMed ID: 29606129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.
    Copenhaver M; Avants SK; Warburton LA; Margolin A
    J Psychoactive Drugs; 2003; 35(2):209-18. PubMed ID: 12924743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.